Latest Articles

The Justice Department crackdown on corrupt practices overseas ensnares both U.S. and foreign companies

MPs and Amnesty International demand to know if a Nottingham-based company has breached the United Nations arms embargo

A television documentary has uncovered flaws in a series of carbon offsetting schemes intended to make good the global warming gases emitted by flights and other polluting activities.

U.S. military has paid $548 million over the past three years to two British security firms that protect the U.S. Army Corps of Engineers on reconstruction projects, more than $200 million over the original budget, according to previously undisclosed data that show how the cost of private security in Iraq has mushroomed.

At least 20,000 police surveillance cameras are being installed along streets here in southern China and will soon be guided by sophisticated computer software from an American-financed company to recognize automatically the faces of police suspects and detect unusual activity.

Wal-Mart, in a struggle to expand its global reach, is trying to enter India through the back door, but many consumers here have taken notice.

Cancer patients in India have reason to be relieved at a high court ruling this week which dismissed a petition by Swiss pharmaceuticals multinational corporation (MNC) Novartis challenging an Indian law which denies patents for minor or trivial improvements to known drugs.

President Gloria Arroyo has ordered an investigation into reports that Filipino workers were forced to go to Iraq to work on the U.S. embassy there despite a ban on them traveling there. A report from the watchdog organization CorpWatch said that "other South Asians" were indeed working for First Kuwait Trading and Contracting in Iraq.

Indian companies will be free to continue making less expensive generic drugs, much of which flow to the developing world, after a court rejected a challenge to the patent law on Monday.

An influential Republican senator says he will propose legislation requiring drug makers to disclose the payments they make to doctors for services like consulting, lectures and attendance at seminars.